This study involved 1736 breast cancer cases and 1895 healthy controls between 20 and 85 years of age and reported that the administration of acetic acid derivatives, propionic acid derivatives, and COX-2 inhibitors was associated with a 24% reduction in breast cancer development. This evidence concerns the gene PTGS2 and breast cancer.